Search

Search Constraints

You searched for: Author/Creator Ventimiglia, Marco

Search Results

1. A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease. Issue 1 (8th June 2020)

2. A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis. Issue 12 (December 2020)

3. A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients With Crohn's Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease. (6th October 2018)

4. A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis. Issue 12 (December 2018)

6. Chest wall infiltration is a critical prognostic factor in breast implant-associated anaplastic large-cell lymphoma affected patients. (May 2021)

8. Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study. Issue 9 (November 2020)

9. Effectiveness and safety of vedolizumab in biologically naïve patients: A real‐world multi‐centre study. Issue 9 (1st November 2020)

10. Effectiveness of Ustekinumab on Crohn's Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD). (1st November 2020)